Insider Trading & Ownership of Christopher Cabell

Location: San Diego, CA
Summary: The estimated net worth of Christopher Cabell is at least $2,001,368 dollars as of 24 Feb 2026. Christopher Cabell is the President & Head of R&D of Inhibikase Therapeutics, Inc. and owns shares of Inhibikase Therapeutics, Inc. (IKT) stock worth about $1.35M. Christopher Cabell is the CMO & Head of R&D of Zura Bio Ltd and owns shares of Zura Bio Ltd (ZURA) stock worth about $648.2K.
Signature: /s/ Mark Iwicki, attorney-in-fact
All Insider Reports: All Insider Reports

Notify me when Christopher Cabell files a new Insider Trading report.

Ownership of Christopher Cabell

Symbol	Company	Relationship	Holdings Value	Report Period
IKT	Inhibikase Therapeutics, Inc.	President & Head of R&D	$1,353,128	21 Feb 2026
ZURA	Zura Bio Ltd	CMO & Head of R&D	$648,240	18 May 2023
PULM	Pulmatrix, Inc.	Director		26 Jan 2023

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.